SCHEMBL1011271

SCHEMBL1011271

CCC(CCO)C1CCO1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SHBG P04278 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4301224 0.88 EPHX1 (0.31)
SCHEMBL1011877 0.86 EPHX1 (0.31)
SCHEMBL4302505 0.83
SCHEMBL28010936 0.82
SCHEMBL8928377 0.81 THRB (0.31)
SCHEMBL13719266 0.79
SCHEMBL11727894 0.78 EPHX1 (0.44)
SCHEMBL3381875 0.78 SMN1; SMN2 (0.31)
SCHEMBL15375792 0.78
SCHEMBL3379499 0.76 SMN1; SMN2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7683104-B2 Curable composition, ink composition, inkjet-recording method, and planographic printing plate FUJIFILM CORPORATION (JP) 2010-03-23 US claimed
US-6495636-B2 A 3-(ETHYLENEOXYALKYLOXYALKYL)OXETANE AND DERIVATIVES; COPOLYMERIZED WITH A 1,1-DIFLUOROETHYLENE OR DERIVATIVE; VERY COMPATIBLE AND COPOLYMERIZABLE WITH UNSATURATED COMPOUNDS; WATERPROOFING; RADIATION TRANSPARENT JSR CORPORATION (JP) 2002-12-17 US claimed
US-9046769-B2 Pattern-forming method, and composition for forming resist underlayer film JSR CORPORATION (JP) 2015-06-02 US disclosed
US-20140371466-A1 PATTERN-FORMING METHOD, AND COMPOSITION FOR FORMING RESIST UNDERLAYER FILM JSR CORPORATION (JP) 2014-12-18 US disclosed
US-8859191-B2 Pattern-forming method, and composition for forming resist underlayer film JSR CORPORATION (JP) 2014-10-14 US disclosed
US-8754179-B2 Light activated shape memory co-polymers CORNERSTONE RESEARCH GROUP, INC. (US) 2014-06-17 US disclosed
US-20120285929-A1 PATTERN-FORMING METHOD, AND COMPOSITION FOR FORMING RESIST UNDERLAYER FILM JSR CORPORATION (JP) 2012-11-15 US disclosed
EP-1783184-B9 Curable ink composition and oxetane compound FUJIFILM CORP (JP) 2011-05-11 EP disclosed
EP-1783184-B1 Curable ink composition and oxetane compound FUJIFILM CORP (JP) 2011-01-05 EP disclosed
US-20100136300-A1 CURABLE COMPOSITION, INK COMPOSITION, INKJET RECORDING METHOD, PRINTED MATERIAL, METHOD OF PRODUCING PLANOGRAPHIC PRINTING PLATE, PLANOGRAPHIC PRINTING PLATE AND OXETANE COMPOUND FUJIFILM CORPORATION (JP) 2010-06-03 US disclosed
US-7728050-B2 Curable composition, ink composition, inkjet recording method, printed matter, method for producing planographic printing plate, planographic printing plate and oxetane compound FUJIFILM CORPORATION (JP) 2010-06-01 US disclosed
EP-1757635-A1 Curable modified oxetane compound and ink composition comprising it Fuji Photo Film Co., Ltd. (JP) 2007-02-28 EP disclosed
WO-2007001407-A2 LIGHT ACTIVATED SHAPE MEMORY CO-POLYMERS CORNERSTONE RESEARCH GROUP, INC. (US) 2007-01-04 WO disclosed
US-7048368-B2 Ink-jet image forming method KONICA CORPORATION (JP) 2006-05-23 US disclosed
US-7014310-B2 Inkjet image forming method and inkjet image forming system KONICA CORPORATION (JP) 2006-03-21 US disclosed
US-20040036753-A1 Ink-jet image forming method KONICA CORPORATION (JP) 2004-02-26 US disclosed
US-20030202079-A1 Inkjet image forming method and inkjet image forming system KONICA CORPORATION (JP) 2003-10-30 US disclosed
US-6495636-B2 A 3-(ETHYLENEOXYALKYLOXYALKYL)OXETANE AND DERIVATIVES; COPOLYMERIZED WITH A 1,1-DIFLUOROETHYLENE OR DERIVATIVE; VERY COMPATIBLE AND COPOLYMERIZABLE WITH UNSATURATED COMPOUNDS; WATERPROOFING; RADIATION TRANSPARENT JSR CORPORATION (JP) 2002-12-17 US disclosed
US-20010002423-A1 Oxetane compound, oxetane copolymer, and process for producing the oxetane compound SUGIYAMA NAOKI (JP) 2001-05-31 US disclosed
EP-1095938-A1 OXETANE COMPOUNDS, OXETANE COPOLYMER, AND PROCESS FOR PRODUCING OXETANE COMPOUNDS JSR Corporation (JP) 2001-05-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120285929-A1 PATTERN-FORMING METHOD, AND COMPOSITION FOR FORMING RESIST UNDERLAYER FILM ADAM9, MUS81, ADAM17 SHBG 1749/4885
US-20100136300-A1 CURABLE COMPOSITION, INK COMPOSITION, INKJET RECORDING METHOD, PRINTED MATERIAL, METHOD OF PRODUCING PLANOGRAPHIC PRINTING PLATE, PLANOGRAPHIC PRINTING PLATE AND OXETANE COMPOUND CCNT1, ACVR2B, ACVR1B SHBG 4601/4885
US-20010002423-A1 Oxetane compound, oxetane copolymer, and process for producing the oxetane compound OXER1, PYM1, AFF1 SHBG 4219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.